# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008847
Filing Date
2022-05-16
Accepted
2022-05-16 07:09:28
Documents
44
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | plx-20220331x10q.htm iXBRL | 10-Q | 788741
2 | EX-31.1 | plx-20220331xex31d1.htm | EX-31.1 | 10027
3 | EX-31.2 | plx-20220331xex31d2.htm | EX-31.2 | 10387
4 | EX-32.1 | plx-20220331xex32d1.htm | EX-32.1 | 6121
5 | EX-32.2 | plx-20220331xex32d2.htm | EX-32.2 | 6147
6 | GRAPHIC | plx-20220331x10q007.jpg | GRAPHIC | 50877
7 | GRAPHIC | plx-20220331x10q005.jpg | GRAPHIC | 98851
8 | GRAPHIC | plx-20220331x10q006.jpg | GRAPHIC | 105331
| Complete submission text file | 0001558370-22-008847.txt |  | 3584301

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | EX-101.SCH | plx-20220331.xsd | EX-101.SCH | 26086
10 | EX-101.CAL | plx-20220331_cal.xml | EX-101.CAL | 33726
11 | EX-101.DEF | plx-20220331_def.xml | EX-101.DEF | 103860
12 | EX-101.LAB | plx-20220331_lab.xml | EX-101.LAB | 186650
13 | EX-101.PRE | plx-20220331_pre.xml | EX-101.PRE | 164548
38 | EXTRACTED XBRL INSTANCE DOCUMENT | plx-20220331x10q_htm.xml | XML | 294430

Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 22925401
SIC: 2836 Biological Products, (No Diagnostic Substances)